Italia markets open in 6 hours 9 minutes

AMGN Oct 2023 200.000 put

OPR - OPR Prezzo differito. Valuta in USD.
Aggiungi a watchlist
0,0600-0,0400 (-40,00%)
Al 10:17AM EDT. Mercato aperto.
Schermo intero
Chiusura precedente0,1000
Aperto0,0600
Denaro0,0500
Lettera0,3800
Prezzo d'esercizio200,00
Scadenza2023-10-20
Min-Max giorno0,0600 - 0,0600
Contratto - Min-MaxN/D
Volume1
Open Interest714
  • GlobeNewswire

    Amgen and TScan Therapeutics Announce Collaboration to Identify Novel Targets in Crohn’s Disease

    Collaboration Brings Together TScan’s Proprietary Target Discovery Platform and Amgen’s Inflammation Therapeutic Expertise and Research Capabilities TScan to Receive $30 Million Upfront With Potential Development and Commercial Milestone Payments of Over $500 Million THOUSAND OAKS, Calif. and WALTHAM, Mass., May 09, 2023 (GLOBE NEWSWIRE) -- Amgen (NASDAQ:AMGN) and TScan Therapeutics, Inc. (NASDAQ:TCRX), today announced a multi-year collaboration that will use TScan’s proprietary target discovery